Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
Clinical trial NCT04614194 · RECRUITING
Trial details
- NCT number
- NCT04614194
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-15
- Primary completion
- 2027-04-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.